01 January

Synch Tech Series – Gene Editing

The Synch Tech Series is a forum where various new technologies are explained, analysed and discussed from technology, business and legal perspectives.

During the last years the field of genome engineering has taken huge steps forward. Along with the progress, many questions have arisen regarding technical development and business possibilities as well as legality and ethical issues. What is possible with genome engineering today? What opportunities lie around the corner or on the horizon? What is legally possible now and in the future? These questions will be discussed when some of the most experienced people within gene editing meet at Synch on 16 February 2016.

Roger Chang is a researcher at KI specializing in cancer and RNA and is the chairman of the RNA society in Stockholm. At the event Roger will give you an insight into the possibilities of modern gene editing techniques and the related costs.

Ryan Bethencourt, from the start-up accelerator Indie Bio in San Francisco, is a scientist, entrepreneur and biohacker who for the last decade has worked in the biopharmaceutical industry to partner on and develop novel drugs. He has had numerous publications in magazines such as Wired, Forbes and TechCrunch and will talk about the business opportunities related to this new technology.

Bo Ekstrand, from Bio Consult AB, has been responsible for a national GMO-network in Sweden since the mid-nineties, focussing on legal and ethical questions regarding genome editing, primarily in the food industry. Bo will give an overview of what is legal today and what is happening (or not happening) within the EU and other parts of the world.

Marie Nyman is the Administrative Director of Gentekniknämnden (the Swedish Gene Technology Advisory Board). Marie has extensive knowledge within the field and will participate in the event and join the following Q&A panel.

The event will be moderated by Hannes Sjöblad. Hannes is an entrepreneur, Singularity University Ambassador and a co-founder of the Swedish biohackers association BioNyfiken. He is passionate about the synthetic biology business and its World changing potential.

17.00 Doors open
17.30 Presentations and Q&A panel
19.00 Networking
21.00 Doors close

Take the opportunity to learn more about gene editing, ask questions to experts within the field and network with the Synch community! Sign up here or send an e-mail to event@synchlaw.se

Nyheder og indsigt

Mandeep Singh Rathour interviewet af K-News


K-News sætter fokus på, at advokatbranchen er præget af en traditionel tilgang og en manglende evne til at omstille forretningsgangene til en ny digital virksomhed tilpasset den yngre generations behov. I denne forbindelse er Mandeep Singh Rathour interviewet om advokatbranchen og bl.a. hvordan Synch har fokus på digital forretning.


Synch og FDIH har samarbejdet om at udvikle et digitalt værktøj, der forsimpler udarbejdelse og tilretning af handelsbetingelser


Synch har udviklet et digitalt værktøj til FDIH (Forening for Dansk Internethandel). Det giver e-handlerne mulighed for effektivt at udarbejde handelsbetingelser, der lever op til lovgivningen.


EU-domstolen fastslår: Anvendelse af cookies kræver aktivt samtykke


EU-domstolen har den 1. oktober 2019 fastslået, at et samtykke, der indhentes ved et forudafkrydset felt, ikke er gyldigt, da der kræves en aktiv handling fra brugeren.




SynchWakeup: Praktisk databeskyttelse – Hvad er status siden 25. maj 2018 afholdes den 29. oktober fra kl. 9:00-12:00.


Synch har indgået et partnerskab TechBBQ, som bygger videre på konceptet TalkBBQ


Synch kan meddele, at vi er partnere til TechBBQ 2019, som afholdes den 18. til 19. september i Øksnehallen i København.


Mandeep Singh Rathour medvirker i podcasten ‘Magtens Tredeling’


Mandeep Singh Rathour medvirker i podcasten, Magtens Tredeling, hos K-News. I podcasten sættes der fokus på, hvordan det finansielle statsregulerede institioner forholder sig til Facebooks kommende kryptoprojekt Libra.